4.38
price down icon0.68%   -0.03
after-market Handel nachbörslich: 4.39 0.010 +0.23%
loading

Finanzdaten der Humacyte Inc-Aktie (HUMA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.51%
26.58
26.18 24.62 26.73 22.51
Interest Income/Expense
5.15%
1.816
1.727 1.463 1.71 1.699
Operating Income/Loss
1.51%
-26.58
-26.18 -24.62 -26.73 -22.51
Nonoperating Income/Loss
594.24%
-5.318
1.076 -1.373 4.025 -14.46
Income/Loss From Continuing Operations Before Tax
27.05%
-31.90
-25.11 -26.00 -22.71 -36.97
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
27.05%
-31.90
-25.11 -26.00 -22.71 -36.97
Net Income/Loss
27.05%
-31.90
-25.11 -26.00 -22.71 -36.97
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
171.31K%
108.25
0.0632 103.44 103.36 103.26
Diluted Average Shares
171.31K%
108.25
0.0632 103.44 103.36 103.26
Basic Earnings Per Share
20.83%
-0.29
-0.24 -0.25 -0.22 -0.36
Diluted Earnings Per Share
20.83%
-0.29
-0.24 -0.25 -0.22 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):